You are viewing a free summary from Descrybe.ai. For citation checking, legal issue analysis, and other advanced tools, explore our Legal Research Toolkit — not free, but close.

In re Biomet Orthopaedics Switz. GMBH Under 28 U.S.C. 1782 for an Order to Take Discovery for Use in a Foreign Proceeding

Citation: 290 F. Supp. 3d 350Docket: MISC. ACTION NO. 17–0158

Court: District Court, E.D. Pennsylvania; November 20, 2017; Federal District Court

Narrative Opinion Summary

In a legal dispute between Heraeus Medical GmbH and Biomet Orthopaedics Switzerland, the Court granted Heraeus' motion to quash Biomet's subpoena. Biomet sought to obtain discovery held by Esschem, Inc.'s counsel for use in a German criminal appeal, but the Court found that the statutory requirements of 28 U.S.C. § 1782 and the discretionary factors from Intel Corp. v. Advanced Micro Devices, Inc. did not support enforcement. The Court noted Biomet's delay in filing the application and the lack of evidence that the German court would accept the discovery. Additionally, the subpoena's demands were seen as excessively intrusive and potentially harmful to Heraeus' proprietary information, especially given Biomet's previous misuse of such information. The Court expressed concern that granting the subpoena could set a precedent for circumventing foreign discovery rules, particularly where parties might inappropriately use § 1782 applications to gain access to opposing counsel's documents. The ruling underscored the importance of balancing international litigation support with the protection of proprietary information and adherence to procedural norms.

Legal Issues Addressed

Application of 28 U.S.C. § 1782

Application: The Court held that even if the statutory requirements of 28 U.S.C. § 1782 are met, it is not obligated to grant the application and must consider discretionary factors.

Reasoning: The Court emphasized that it is not obligated to grant a § 1782 application even if the statutory criteria are satisfied.

Discretionary Factors in § 1782 Applications

Application: The Court found that the discretionary factors outlined in Intel Corp. v. Advanced Micro Devices, Inc. weighed against enforcing the subpoena, particularly the nature of foreign litigation and the receptivity of the foreign jurisdiction.

Reasoning: The second Intel factor, assessing the nature of foreign litigation and the receptivity of the foreign jurisdiction to U.S. court assistance, is unfavorable for enforcing the subpoena.

Precedent Concerns in International Discovery

Application: The Court warned against setting a precedent that could allow misuse of § 1782 applications to bypass foreign discovery protocols.

Reasoning: Concerns regarding the first and third Intel factors highlight the potential for setting a problematic precedent where parties misuse 1782 applications to acquire opposing counsel's documents.

Protection of Proprietary Information

Application: Enforcing the subpoena would violate protective orders and could expose Heraeus' proprietary information, given Biomet's previous misuse of such information.

Reasoning: Granting this request would violate the protective order's intent and could expose Heraeus' proprietary information, especially given past findings of Biomet's misuse of such information in Germany.

Timeliness and Procedural Conduct in Discovery Requests

Application: Biomet's delay in seeking the 1782 application undermined its case, as it failed to demonstrate the German court's receptivity to the discovery at a late stage.

Reasoning: Biomet's delay in seeking the 1782 application undermines its case, as it has not demonstrated that the German court would accept such extensive discovery at this late stage.